Skip to main content

Thursday 7 november

Room I – Madurozaal

Keynote session day 1: Interprofessional Teamwork

Chair: Thomas Ottens/Leiv Otto Watne

TimeSubjectSpeaker
09.00 – 09.10
Welcome from the mayor of Madurodam

Mayor of Madurodam

09.10 – 09.20
Welcome from the President of the EDA

Leiv Otto Watne (President EDA)

09.20 – 10.05
Keynote: Virtual Critical Care, lessons for interprofessional teamwork

Björn Weiss (Charité Universitätsmedizin Berlin, Germany)

10.05 – 10.15
Discussion

10.15 – 10.45
Coffee break

Update: Perioperative Delirium

Chair: Thomas Ottens

TimeSubjectSpeaker
10.45 – 11.10
The 2023 ESAIC postoperative delirium guideline: what’s new?

Björn Weiss (Charité Universitätsmedizin Berlin, Germany)

11.10 – 11.35
Decision science and predicting delirium

Odette Wegwarth (Charité Universitätsmedizin Berlin, Germany)

11.35 – 12.00
Masterclass: Guideline implementation

Erwin Ista (Erasmus MC Rotterdam, The Netherlands)

12.00 – 12.15
Discussion

12.15 – 13.15
Lunch
12.30 – 13.15
Guided poster tour

Artificial Intelligence (AI) in Delirium Research

Chair: Heidi Lindroth

TimeSubjectSpeaker
13.15 – 13.45
Delirium is in the AI of the beholder

Alex Tsui (University College London, UK)

13.45 – 14.15
The fallacy of interpretability: Lessons from Delirium

Parashkev Nachev (University College London, UK)

14.15 – 14.35
Ethics & AI

Michel van Genderen (Erasmus MC Rotterdam, The Netherlands)

14.35 – 14.45
Discussion
14.45 – 15.15
Afternoon coffee break

Long term outcomes in ICU survivors: comparing experiences from the US & Europe

Chair: Mark van den Boogaard

TimeSubjectSpeaker
15.15 – 15.40
Post-Intensive Care Syndrome: Risk Factors, Outcomes, and Development of a Population-Level Risk Score

Sikandar Khan (Indiana University, USA)

15.40 – 16.05
Life after Delirium: Long-term Outcomes in a Large, Community-Based Cohort in the Netherlands

Rens Kooken (Radboudumc, The Netherlands)

16.05 – 16.30
Clinical Trajectories Among Acute Respiratory Failure Survivors with Delirium in the US: A Real-world Experience

Babar Khan (Indiana University, USA)

16.30 – 16.45
Discussion

16.45 – 17.00
Afternoon coffee break

Pediatric and Neonatal Delirium

Chair: Jacqueline Strik

TimeSubjectSpeaker
17.00 – 17.25
Health-related quality of life (HRQoL) after PICU admission and the influence of pediatric delirium

Kim Tijssen (Maastricht UMC+, The Netherlands)

17.25 – 17.50
Delirium in the NICU: Fact or Fiction?

Husam Salamah (Maastricht UMC+, The Netherlands)

17.50 – 18.00
Discussion

18.00
End of programme
19.00
Walking dinner

ROOM II – Boon van der Starpzaal

Delirium Pharmacotherapy into the future

Chair: Leiv Otto Watne

TimeSubjectSpeaker
10.45 – 11.10
Haloperidol

Mathieu van der Jagt (Erasmus MC Rotterdam, The Netherlands)

11.10 – 11.35
Alpha-2-agonists

Björn Erik Neerland (Universitetssykehus Oslo, Norway)

11.35 – 12.00
Intranasal Insulin

Gideon Caplan (UNSW Sydney, Australia)

12.00 – 12.15
Discussion

12.15 – 13.15
Lunch
12.30 – 13.15
Guided poster tour
12.15 – 13.15
Lunch Symposium: QUMEA

Delirium Management 2.0: Adding AI Sensor Technology

Delirium Management 2.0: Adding AI Sensor Technology

The symposium explores innovative approaches to managing delirium when critical care is no longer needed in the ICU. The focus of our presentations is the implementation of non-pharmacological measures for patients experiencing delirium in an acute geriatric care environment. We will demonstrate how we simultaneously avoided the use of physical restraints and fostered mobility by integrating AI-based technology. Additionally, we will illustrate, how AI-based technology helped reduce sensory overload. This session highlights the pioneering work of the University Department of Geriatric Medicine Felix Platter in Basel, which established a specialized delirium unit. Key discussions include the use of AI sensor technology to reduce falls in patients with delirium, observed fall patterns on specialized units, and nurses’ perceptions of AI-driven bed-exit warnings. By integrating AI technologies, this approach aims to enhance both patient outcomes and healthcare efficiency in delirium care.

Our speakers:

  • Cyrill Gyger, CEO QUMEA AG: AI-Based Mobility Monitoring for Patient Safety
  • Dr. Isabella Glaser, Universitäre Altersmedizin FELIX PLATTER: Pioneering a Dedicated Delirium Unit in Basel – Copy, Paste for Better Patient Outcomes!
  • Dr. phil. Wolfgang Hasemann, Universitäre Altersmedizin FELIX PLATTER: AI-Sensor Based Falls Reduction in Patients with Delirium
  • Tamara Eichenbrenner, Universitäre Altersmedizin FELIX PLATTER: Fall Patterns in Patients with Delirium Observed on a Specialized Unit
  • Valerie Rhyser, Universitäre Altersmedizin FELIX PLATTER: Nurses’ Perception of AI-Sensor Based Bed-Exit Warnings on a Specialized Unit

Delirium in Special Patient Groups

Chair: Arjen Slooter

TimeSubjectSpeaker
13.15 – 13.40
Pediatrics: Delirium in Children

Jacqueline Strik (Maastricht University, The Netherlands)

13.40 – 14.05
Geriatrics: Delirium in Dementia & very old age

Daniel Davis (University College London, UK)

14.05 – 14.30
Post-stroke delirium

Sylvie de Raedt (UZ Bruxelles, Belgium)

14.30 – 14.45
Discussion

14.45 – 15.15
Afternoon coffee break

Best Abstract Session I

Chair: Cynthia Olotu

TimeSubjectSpeaker
15.15 – 16.45
Best Abstract Session, Pathophysiology and brain/EEG

16.45 – 17.00
Afternoon coffee break

American Delirium Society – Submitted Symposium

Chair: Noll Campbell/Leiv Otto Watne

TimeSubjectSpeaker
17.00 – 18.00
Organizational, Scientific, And Clinical Updates from the ADS

Noll Campbell (Purdue University)

TimeSubjectSpeaker
18.00 – 19.00
EDA General Assembly

ROOM III – Oranjezaal

Workshop Delirium in the Palliative phase

Chair: An Reyners

TimeSubjectSpeaker
13.15 – 13.35
Palliative Sedation following Delirium, a case

Jenske Geerling (UMC Groningen)

13.35 – 13.55
Integration of Palliative and Geriatric Approaches

Josephine Stoffels (Amsterdam UMC)

13.55 – 14.15
The Role of Biomarkers in Predicting and Early Detection of Delirium

Lia van Zuylen (Amsterdam UMC)

14.15 – 14.35
The Role of Medication, Including Intermittent Nocturnal Sedation

Meera Agar (University of Technology Sydney)

14.35 – 14.45
Discussion

Delirium at the end of life often provides specific challenges to health care professionals involved. Since the underlying somatic factors are of a progressive nature, delirium symptoms tend to increase despite standard anti-delirium measures. In this interactive workshop, we will point at tensions between geriatric versus palliative approaches to these patients and provide suggestions to integrate these approaches. Also, we will explore whether early detection with biomarkers could play a beneficial role. Finally, we will examine the roles of antipsychotic and sedating medication.

14.45 – 15.15
Afternoon coffee break

Beste Abstract Session II

Chair: Jacqueline Strik

TimeSubject
15.15 – 16.45
Beste Abstract Session, Screening and risk assessment